Pacira BioSciences (PCRX) logo

PCRX earnings date, and what happened the last 4 times

Next report

Thu Nov 5

Quality Score today 17

After the close, in 10 days. Expected: the company has not confirmed it.

PCRX closed higher after 1 of its last 4 reports. On average it closed -3.1% the session after a report.

The moment PCRX reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when PCRX reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after PCRX's last 4 reports

PCRX's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 4, 20262026 · After close18estimated-5.7%-10.0%
Apr 30, 20262026 · After close12estimated+5.5%-4.1%
Feb 26, 20262026 · After close3estimated-6.4%-3.0%
Nov 6, 20252025 · After close1estimated-3.7%+4.5%
  • Aug 4, 2026, after the close: the next session PCRX opened -5.7% and closed -10.0%, and five sessions on it stood -11.7%. Its Quality Score going in was 18 (Excellent), estimated.
  • Apr 30, 2026, after the close: the next session PCRX opened +5.5% and closed -4.1%, and five sessions on it stood -7.3%. Its Quality Score going in was 12 (Above Average), estimated.
  • Feb 26, 2026, after the close: the next session PCRX opened -6.4% and closed -3.0%, and five sessions on it stood +1.2%. Its Quality Score going in was 3 (Below Average), estimated.
  • Nov 6, 2025, after the close: the next session PCRX opened -3.7% and closed +4.5%, and five sessions on it stood +11.9%. Its Quality Score going in was 1 (Below Average), estimated.

Across these 4 reports PCRX opened higher after 1 of 4 and closed higher after 1 of 4; on average it opened -2.6%, closed -3.1%, and stood -1.5% five sessions on. Its Quality Score is 17 today, against 18 going into its Aug 4, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -10.0% after the Aug 4, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see PCRX's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about PCRX's earnings

As of Oct 26, 2026: Pacira BioSciences (PCRX): expected to report Thu Nov 5, after the close. PCRX closed higher after 1 of its last 4 reports. Its Quality Score is 17 (Excellent). Scores as of 10:16 PM ET, 15 minutes behind.

When is PCRX's next earnings date?

Expected to report Thu Nov 5, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. PCRX closed higher after 1 of its last 4 reports. Past behavior, not a forecast.

Does PCRX report before or after the market?

PCRX is expected to report Thu Nov 5, after the close. Its last 4 reports came after the close.

How did PCRX stock react to its last earnings report?

Aug 4, 2026, after the close: the next session PCRX opened -5.7% and closed -10.0%, and five sessions on it stood -11.7%.

Does PCRX stock usually go up after earnings?

PCRX closed higher after 1 of its last 4 reports. On average it closed -3.1% the session after a report, after opening -2.6%. Past behavior, not a forecast.

Pacira BioSciences' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.